共 573 条
[1]
Renoux C(2007)Natural history of multiple sclerosis with childhood onset N Engl J Med 356 2603-2613
[2]
Vukusic S(2016)Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases Neurology 87 S12-S19
[3]
Mikaeloff Y(2002)Testing medications in children N Engl J Med 347 1462-1470
[4]
Edan G(2013)Disease-modifying therapy of pediatric multiple sclerosis Neurotherapeutics. 10 89-96
[5]
Clanet M(2017)Randomized clinical trials (RCTs) in pediatric multiple sclerosis: are they really necessary? Mult Scler 23 1042-1043
[6]
Dubois B(2018)Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US Neurology 91 e1778-e1787
[7]
Bar-Or A(2008)Effectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: a comparative cohort study Eur J Paediatr Neurol 12 205-209
[8]
Hintzen RQ(2006)Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis Neurology. 66 472-476
[9]
Dale RC(2016)Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study J Neurol Sci 363 33-38
[10]
Rostasy K(2001)Interferon-beta treatment in patients with childhood-onset multiple sclerosis J Pediatr 139 443-446